| Literature DB >> 36006243 |
Rattapon Uppala1, Phanthila Sitthikarnkha1, Sirapoom Niamsanit1, Sumitr Sutra1, Kaewjai Thepsuthammarat2, Leelawadee Techasatian1, Nattachai Anantasit3, Jamaree Teeratakulpisarn1.
Abstract
BACKGROUND: The COVID-19 outbreak emerged in January 2020 and remains present in 2022. During this period, nonpharmaceutical interventions (NPIs) have been used to reduce the spread of COVID-19 infection. Nationwide data analysis should be pushed as the new standard to demonstrate the impact of COVID-19 infection on other respiratory illnesses and the reliability of NPIs during treatment.Entities:
Keywords: COVID-19; children; hospitalization; lower respiratory tract infection; nonpharmaceutical interventions
Year: 2022 PMID: 36006243 PMCID: PMC9414978 DOI: 10.3390/tropicalmed7080151
Source DB: PubMed Journal: Trop Med Infect Dis ISSN: 2414-6366
The proportion of LRTIs in hospitalized children during the fiscal years 2015–2020.
| Fiscal Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total |
|---|---|---|---|---|---|---|---|
| Total | 235,316 | 294,436 | 281,510 | 329,657 | 282,590 | 186,651 | 1,610,160 |
| Gender, N (%) | |||||||
| Male | 140,165 (59.56) | 171,817 (58.35) | 164,619 (58.48) | 193,533 (58.71) | 164,987 (58.38) | 109,400 (58.61) | 944,521 |
| Age group, N (%) | |||||||
| <1 year | 57,903 (24.61) | 70,313 (23.88) | 64,753 (23.00) | 82,424 (25.00) | 61,280 (21.69) | 42,247 (22.63) | 378,920 |
| 1–<5 years | 141,875 (60.29) | 174,129 (59.14) | 162,349 (57.67) | 194,000 (58.85) | 157,037 (55.57) | 103,718 (55.57) | 933,108 |
| 5–<18 years | 35,538 (15.10) | 49,994 (16.98) | 54,408 (19.33) | 53,233 (16.15) | 64,273 (22.74) | 40,686 (21.80) | 298,132 |
| Principal diagnosis, N (%) | |||||||
| Pneumonia (J09–J18) | 130,943 (55.65) | 179,434 (60.94) | 176,352 (62.65) | 207,382 (62.91) | 182,446 (64.56) | 120,281 (64.44) | 996,838 |
| Bronchiolitis (J21) | 31,121 (13.23) | 31,535 (10.71) | 27,493 (9.77) | 34,037 (10.32) | 25,067 (8.87) | 16,037 (8.59) | 165,290 |
| Bronchitis (J20) | 73,252 (31.13) | 83,467 (28.35) | 77,665 (27.59) | 88,238 (26.77) | 75,077 (26.57) | 50,333 (26.97) | 448,032 |
| Region, N (%) | |||||||
| Bangkok | 10,304 (4.38) | 13,224 (4.49) | 11,839 (4.21) | 12,464 (3.78) | 10,736 (3.80) | 6371 (3.41) | 64,938 |
| Central | 45,402 (19.29) | 58,494 (19.87) | 55,588 (19.75) | 64,445 (19.55) | 55,122 (19.51) | 34,669 (18.57) | 313,720 |
| East | 13,827 (5.88) | 16,947 (5.76) | 16,609 (5.90) | 18,719 (5.68) | 15,492 (5.48) | 8922 (4.78) | 90,516 |
| Northeast | 83,335 (35.41) | 111,398 (37.83) | 105,592 (37.51) | 125,414 (38.04) | 98,332 (34.80) | 68,684 (36.80) | 592,755 |
| North | 20,424 (8.68) | 23,906 (8.12) | 22,609 (8.03) | 28,562 (8.66) | 26,815 (9.49) | 18,428 (9.87) | 140,744 |
| West | 12,360 (5.25) | 15,735 (5.34) | 14,435 (5.13) | 18,356 (5.57) | 15,730 (5.57) | 10,162 (5.44) | 86,778 |
| South | 49,664 (21.11) | 54,732 (18.59) | 54,838 (19.48) | 61,697 (18.72) | 60,363 (21.36) | 39,415 (21.12) | 320,709 |
| Level of hospital, N (%) | |||||||
| Primary | 16,299 (6.93) | 21,319 (7.24) | 20,683 (7.35) | 25,926 (7.86) | 21,032 (7.44) | 14,049 (7.53) | 119,308 |
| Secondary | 173,335 (73.66) | 215,586 (73.22) | 208,757 (74.16) | 246,822 (74.87) | 212,567 (75.22) | 142,217 (76.19) | 1,199,284 |
| Tertiary | 37,898 (16.11) | 47,275 (16.06) | 43,263 (15.37) | 48,288 (14.65) | 40,856 (14.46) | 25,748 (13.79) | 243,328 |
| Private | 7784 (3.31) | 10,256 (3.48) | 8807 (3.13) | 8621 (2.62) | 8135 (2.88) | 4637 (2.48) | 48,240 |
Figure 1Number of hospitalized LRTIs in fiscal years 2015–2020.
Figure 2Number of LRTI admissions by month in fiscal year 2019 compared with 2020 in Thailand.
Number of children hospitalized with LRTIs during the COVID-19 pandemic (2020) compared to the previous five years (2015–2019).
| 2015–2019 | 2020 | ||
|---|---|---|---|
| Total | 1,423,509 (88.41) | 186,651 (11.59) | |
| Principal diagnosis, N (%) | <0.001 | ||
| Pneumonia (J09–J18) | 876,557 (61.58) | 120,281 (64.44) | |
| Bronchiolitis (J21) | 149,253 (10.48) | 16,037 (8.59) | |
| Bronchitis (J20) | 397,699 (27.94) | 50,333 (26.97) | |
| Sex, N (%) | 0.786 | ||
| Male | 835,121 (58.67) | 109,400 (58.61) | |
| Female | 588,388 (41.33) | 77,251 (41.39) | |
| Age group, N (%) | <0.001 | ||
| <1 year | 336,673 (23.65) | 42,247 (22.63) | |
| 1–<5 years | 829,390 (58.26) | 103,718 (55.57) | |
| 5–<18 years | 257,446 (18.09) | 40,686 (21.80) | |
| Region, N (%) | <0.001 | ||
| Bangkok | 58,567 (4.11) | 6371 (3.41) | |
| Central | 279,051 (19.60) | 34,669 (18.57) | |
| East | 81,594 (5.73) | 8922 (4.78) | |
| Northeast | 524,071 (36.82) | 68,684 (36.80) | |
| North | 122,316 (8.59) | 18,428 (9.87) | |
| West | 76,616 (5.38) | 10,162 (5.44) | |
| South | 281,294 (19.76) | 39,415 (21.12) | |
| Hospital level, N (%) | <0.001 | ||
| Primary | 105,259 (7.39) | 14,049 (7.53) | |
| Secondary | 1,057,067 (74.26) | 142,217 (76.19) | |
| Tertiary | 217,580 (15.28) | 25,748 (13.79) | |
| Private | 43,603 (3.06) | 4637 (2.48) |
Incidence per 1000 person-years during the COVID-19 pandemic (2020) compared to the previous five years (2015–2019).
| Principal Diagnosis | 2015–2019 | 2020 | IRR (95%CI) |
|---|---|---|---|
| Pneumonia (J09–J18) | 12.77 | 9.16 | 0.72 (0.71, 0.72) |
| Bronchitis (J20) | 5.79 | 3.84 | 0.66 (0.65, 0.67) |
| Bronchiolitis (J21) | 2.17 | 1.22 | 0.56 (0.55, 0.57) |
IRR, incidence rate ratio; CI, confidence interval.
Figure 3Total costs of all lower respiratory infections by month in fiscal year 2019 compared with 2020 in Thailand.